Literature DB >> 2688075

Reassessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis.

T Pincus1, L F Callahan.   

Abstract

Twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis have provided much of the conventional wisdom in textbooks and clinical practice. Reassessment of these paradigms may lead to new insights and improved outcomes in rheumatoid arthritis.

Entities:  

Mesh:

Year:  1989        PMID: 2688075     DOI: 10.3109/03009748909092614

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  16 in total

Review 1.  International variation in resource utilisation and treatment costs for rheumatoid arthritis: a systematic literature review.

Authors:  Hubertus Rosery; Rito Bergemann; Stefanie Maxion-Bergemann
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 2.  Prognostic factors of severe rheumatoid arthritis.

Authors:  R Westhovens
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

3.  A Human Monoclonal Antibody Against Tumor Necrosis Factor-alpha.

Authors: 
Journal:  P T       Date:  2009-11

Review 4.  Assessment of quality of life in rheumatoid arthritis: methods and implications.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

5.  Treatment perspectives in rheumatoid arthritis: a descriptive study in a Swedish healthcare district.

Authors:  P Bendtsen; P Bjurulf; E Trell; F Lindström; J E Larsson
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

Review 6.  A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings.

Authors:  D P Lubeck
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 7.  New therapies for rheumatoid arthritis.

Authors:  F Goldblatt; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

Review 8.  The underestimated long term medical and economic consequences of rheumatoid arthritis.

Authors:  T Pincus
Journal:  Drugs       Date:  1995       Impact factor: 9.546

9.  Guidelines for the use of cyclosporine in rheumatoid arthritis.

Authors:  P Tugwell; P Baker
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 10.  Is rheumatoid arthritis disappearing?

Authors:  T Uhlig; T K Kvien
Journal:  Ann Rheum Dis       Date:  2004-07-29       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.